Outcomes of complete responders from first-line therapy in metastatic renal cell carcinoma in the real world: an analysis from the International Metastatic Renal Cell Carcinoma Database Consortium

Key Points

• To evaluate the outcomes of patients who achieve complete response after first-line therapy for metastatic renal cell carcinoma.
• Utilized data from the International Metastatic Renal Cell Carcinoma Database Consortium
• Identified patients who were complete responders to first-line therapy
• Analyzed real-world clinical outcomes over a defined follow-up period
• Complete responders demonstrated significantly improved survival rates
• Overall quality of life metrics were favorable compared to non-responders
• Long-term follow-up revealed sustained responses in many complete responders